How does chemo brain work? One cancer drug might interfere with brain signaling

How does chemo brain work? One cancer drug might interfere with brain signaling
For the millions of people treated for cancer, chemo brain can be an unnerving and disabling side effect. It causes memory lapses, trouble concentrating, and an all-around mental fog, which appear linked to the treatment and not the disease. Although the cognitive effects often fade after chemotherapy ends, for some people the fog persists for years, even decades. And doctors and researchers have long wondered why. Now, a new study suggests an answer in the case of one chemotherapy drug: Brain cells called microglia may orchestrate chemo brainby disrupting other cells that help maintain the brains communication system.

I cant tell you how many patients I see who look at me when I explain [chemo brain] and say, Ive been living with this for 10 years and thought I was crazy, says Michelle Monje, a pediatric neuro-oncologist and neuroscientist at Stanford University in Palo Alto, California. Its still mostly a mystery how common long-term cognitive impairment is after chemo. In one recent study by clinical neuropsychologist Sanne Schagen at the Netherlands Cancer Institute in Amsterdam, 6 months after treatment.

Monje began to probe the cognitive effects of cancer treatment in the early 2000s, starting with radiation, a therapy that can be far more debilitating than chemotherapy. A


paper she and her colleagues published in 2003 suggested radiation affected a type of brain cell called microglia , which protect the brain against inflammation. Just like immune cells in the blood, microgliawhich make up at least 10% of all brain cellsbecome activated during injury or infection.

Monje began the new study almost 7 years ago. First, she and her colleagues examined stored brain tissue samples from children and young adults who had died from various cancers, and control patients whod died of something else. Some had received a host of chemotherapy drugs, and some had never gotten chemotherapy. In those whod had chemo, OPCs were markedly depleted, but only in the white matter of the brain, which is a heavily myelinated brain region. The researchers focused on a particular chemotherapy drug, methotrexate, which is especially associated with long-term cognitive problems.

Monjes team wanted to confirm the findings in just-donated tissue, which was offered to them by the families of two children: a 3-year-old whose brain cancer was treated with high doses of methotrexate, and a 10-year-old whose brain cancer progressed so rapidly that there was no time to administer much therapy. Again, the child whod received methotrexatewith the last dose well over a month before he diedhad a near-wipeout of OPCs in white matter. The other child did not.

Next up for the scientists was designing a mouse model of chemo brain caused by methotrexate. The mice got the same chemotherapy treatment as the 3-year-old, adjusted for their tiny body size. The animals have a very clear impairment in attention and short-term memory, Monje says. The animals also had the same decrease in white matter OPCs. Studying the organ 6 months after chemotherapy endeda long time in the life of a mousethe researchers saw that the myelin sheaths were thinner, Monje says, which would disrupt brain signaling.

The big question for Monje was whether chemotherapy was directly killing OPCs or creating an environment that was hostile to them. To answer this, her team transplanted healthy OPCs into the brains of mice previously administered methotrexate. Those healthy cells showed the same disregulation, Monje says. Typically, the brain replenishes OPCs as needed, but in the mice, it didnt. Something in the brains environment was causing the cells decay and disappearance.

Ultimately, the story came full circle back to the microglia that Monje had first eyed more than 15 years ago. Additional experiments on brain cells revealed methotrexate activates microglia in the brains white matter, causing a cascade of effects and ultimately depleting OPCs. Because several compounds that deplete microglia are in clinical trials for cancer and other indications, the scientists were able to test one of them on their chemo brainaffected animals. They found that depleting microglia was effective: It restored OPCs, normalized myelin, and rescued short-term memory, the research team reports today in


. That means, they write, for this particular drug.

The authors did a great job at trying to look at this phenomenon from very different angles, says Schagen, making sure, for example, that findings in brain tissue also held true in mice. The activation of microglia, Schagen says, looks like an important direct mechanism. But Schagen, who has studied the effects of several chemotherapy drugs on mouse brains, also stresses that these findings are limited to methotrexate; other chemotherapy drugs may cause cognitive problems in different ways. The dose and its timing may also affect a drugs brain effects, Schagen says.

Monje says theres a lot left to do before launching a clinical trial of any potential chemo brain fighter. One question is how long any such drug must be used. Another is what molecular mechanisms are driving the brain cells to behave as they do. But shes hopeful that, after many years of trying, she and others are moving in the right direction.
News Topics :
New  developments and research into  treating Alzheimer’s disease  are always welcome. Researchers from the Department of General Anesthesiology at the Cleveland Clinic Lerner College of Medicine have developed a drug...
By blocking a protein s activity with antibodies, Stanford University School of Medicine investigators were able to improve cognitive behavior in aging mice. advertisement A paper describing the finding will...
After undergoing surgery, elderly patients often experience cloudy thinking that can last for weeks or even months. At one time researchers thought this cognitive decline might be caused by anesthesia,...
Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated. advertisement The study, published...
Scientists have identified two topical drugs miconazole and clobetasol capable of stimulating regeneration of damaged brain cells and reversing paralysis in animal models of MS. Two FDA approved drugs were...